Latest filing published 13 May 2019 for Trevi Therapeutics, Inc., €998k.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -68.4%Entry US$8.90 · Close at T+365 US$2.81
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Aperture Venture Partners IV, L.P.: trading record in brief
Aperture Venture Partners IV, L.P. is a declared insider of Trevi Therapeutics, Inc., with filings sourced from SEC (Form 4). In total, 2 filings cover trades dated 9 May 2019.
On the market, this insider has only ever bought: 1 purchase, €998k in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
The latest filing, published on 13 May 2019, reports an open-market purchase of €998k in Trevi Therapeutics, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Aperture Venture Partners IV, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 112,000 shares@ US$10.00100.0% of flowCommon StockSEC:0000899243-19-013254:1Canonical exit: 7 Aug 2019 (T+90)
- 232,963 sharesCommon StockSEC:0000899243-19-013254:0
2 of 2 declarations
